Zobrazeno 1 - 10
of 679
pro vyhledávání: '"P Whorwell"'
Autor:
Zoltan Kekecs PhD, Donald Moss PhD, Peter J. Whorwell MD, PhD, Katalin Varga PhD, Devin B. Terhune PhD, Philip D. Shenefelt MD, Olafur S. Palsson PsyD, Giuseppe De Benedittis MD, PhD, Gary Elkins PhD
Publikováno v:
Journal of Evidence-Based Integrative Medicine, Vol 29 (2024)
There is an abundance of outcomes research for clinical hypnosis showing promising results. Nonetheless, hypnosis is still underutilized in clinical care. For a behavioral intervention to enter mainstream clinical care, efficacy needs to be demonstra
Externí odkaz:
https://doaj.org/article/8c0a4608cffa4562834f6f37cb1cec4b
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Stimulant laxatives are well established as first- or second-line treatments for constipation and although they have a reliable therapeutic effect, alleged safety concerns still exist, particularly with long-term use. The potential harmful effects on
Externí odkaz:
https://doaj.org/article/af5b6879588f46f1948c7b60ac8cc3c8
Autor:
David Gunn, Rabia Topan, Ron Fried, Ivana Holloway, Richard Brindle, Suzanne Hartley, Lorna Barnard, Maura Corsetti, S Mark Scott, Adam Farmer, Ayesha Akbar, Maria Eugenicos, Nigel Trudgill, Kapil Kapur, John McLaughlin, David S Sanders, Arvind Ramadas, Peter Whorwell, Lesley Houghton, Phil G Dinning, Qasim Aziz, Alexander C Ford, Amanda Farrin, Robin Spiller
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 10, Iss 09 (2023)
Background Irritable bowel syndrome with diarrhoea is characterised by frequent, loose or watery stools with associated urgency, resulting in marked reduction of quality of life. Ondansetron, a 5-hydroxytryptamine-3 receptor antagonist, has been show
Externí odkaz:
https://doaj.org/article/8e3c4c5bb58043b1b6ee827497831e62
Publikováno v:
JGH Open, Vol 6, Iss 7, Pp 447-453 (2022)
Abstract Background and Aim Recent studies have highlighted the high worldwide prevalence of irritable bowel syndrome (IBS) and disparities in its management between ethnic groups. For instance, gut‐directed hypnotherapy (GDH), one of the most effe
Externí odkaz:
https://doaj.org/article/4ca6bc64178a481caeeedf1e0966b224
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Objective Gut-directed hypnotherapy (GDH) is an evidence-based treatment for irritable bowel syndrome (IBS). Adoption of remote GDH has been accelerated by the COVID-19 pandemic. We aimed to evaluate patient experience and satisfaction following remo
Externí odkaz:
https://doaj.org/article/27e19045141c424f90d30b8cb5056bbe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anu Kemppinen, Carol Howell, Victoria Allgar, Matthew Dodd, John Gregson, Charles Knowles, John McLaughlin, Preeti Pandya, Peter Whorwell, Elena Markaryan, Yan Yiannakou
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Abstract Background Irritable bowel syndrome (IBS) with diarrhoea (IBS-D) is a common and chronic condition that can significantly impair quality of life. The emergence of new drugs for IBS-D has been slow and there is a need for new treatments, incl
Externí odkaz:
https://doaj.org/article/c4eb6c5fc5314649afa5835e05a346ad
Autor:
Huda Badri, Carmen Gibbard, Dimitra Denton, Imran Satia, Bashar Al-Sheklly, Rachel J. Dockry, Kimberley Holt, Kevin McGuiness, Sam Treadway, Peter Whorwell, Lesley Houghton, Augustine Lee, K. Jane Escott, Theresa Lee, Greame Wilkinson, Alison Holt, Brendan J. Canning, Jacky A. Smith
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Objective Baclofen is a centrally acting γ-aminobutyric acid type B (GABAB) receptor agonist which reduces gastro-oesophageal reflux and suppresses the cough reflex; however, central nervous system side-effects limit its use. Lesogaberan is a novel
Externí odkaz:
https://doaj.org/article/cf3a12b94f2440f4b3583988978dc4f8
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Introduction: Numerous studies have shown that hypnotherapy (HT) is effective in irritable bowel syndrome (IBS) using traditional symptom severity end points. However, there is now interest in capturing the patient’s perception of their illness and
Externí odkaz:
https://doaj.org/article/87af720d6f7a4d93b1603c8687de1c13
Autor:
David Gunn, Ron Fried, Rabia Lalani, Amanda Farrin, Ivana Holloway, Tom Morris, Catherine Olivier, Rachael Kearns, Maura Corsetti, Mark Scott, Adam Farmer, Anton Emmanuel, Peter Whorwell, Yan Yiannakou, David Sanders, John Mclaughlin, Kapil Kapur, Maria Eugenicos, Ayesha Akbar, Nigel Trudgill, Lesley Houghton, Phil G. Dinning, Alexander C. Ford, Qasim Aziz, Robin Spiller
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background Irritable bowel syndrome with diarrhoea (IBS-D) affects up to 4% of the general population. Symptoms include frequent, loose, or watery stools with associated urgency, resulting in marked reduction of quality of life and loss of w
Externí odkaz:
https://doaj.org/article/666fe80d7c1f434ab737aefe79301cbd